Real ‐world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study

ConclusionThis study revealed the heterogeneity of treatment patterns and survival outcomes in patients with stage III NSCLC before durvalumab consolidation came into clinical practice. There is an unmet need for patients who are not eligible for surgery as an initial therapy. Novel therapeutic approaches are highly warranted to improve clinical outcomes.

Source: Cancer Medicine - April 16, 2024 Category: Cancer & Oncology Authors: Jiyun Lee, Hee Kyung Ahn, Sang ‐We Kim, Ji‐Youn Han, Sung Sook Lee, Hyung Soon Park, Hyun Woo Lee, Joo‐Hang Kim, Eunhan Cho, Reto Huggenberger, Byoung Chul Cho Tags: RESEARCH ARTICLE Source Type: research